Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cassava Sciences Inc SAVA

Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on neuroscience. The Company's science is based on stabilizing, but not removing, a critical protein in the Alzheimer’s brain. Its scientific approach for the treatment of Alzheimer's disease seeks to simultaneously suppress both neurodegeneration and neuroinflammation. It has two biopharmaceutical assets under... see more

Recent & Breaking News (NDAQ:SAVA)

SAVA INVESTOR ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Cassava Sciences, Inc.

Newsfile September 1, 2021

Lawsuits Filed Against PLL, KPLT and SAVA - Jakubowitz Law Pursues Shareholders Claims

Accesswire September 1, 2021

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Cassava Sciences, Inc. (SAVA) Investors with Losses to Contact Firm's Attorneys Now, Securities Fraud Class Period Expanded

PR Newswire September 1, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BLCT, LIVE and SAVA

Accesswire September 1, 2021

SAVA ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Cassava Sciences, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case

Business Wire August 31, 2021

SHAREHOLDER ALERT: Robbins LLP Announces that Cassava Sciences, Inc. (SAVA) is Being Sued for Misleading Shareholders

Business Wire August 31, 2021

Cassava Sciences News: Berger Montague Investigates Securities Fraud Allegations Against Cassava Sciences Inc. (SAVA); Lead Plaintiff Deadline is October 26, 2021

Newsfile August 31, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Cassava Sciences, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 26, 2021 - SAVA

Newsfile August 31, 2021

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Cassava Sciences, Inc. (SAVA) Investors to Contact Firm's Attorneys Now, Securities Fraud Class Period Expanded

Newsfile August 31, 2021

SAVA LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Cassava Sciences, Inc.

Newsfile August 31, 2021

SAVA INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Cassava Sciences, Inc.

PR Newswire August 31, 2021

LAWSUIT FILED - Expanded Class Period: CASSAVA SCIENCES Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information

Newsfile August 31, 2021

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Cassava Sciences, Inc. (SAVA) Investors

Business Wire August 31, 2021

CLASS ACTION UPDATE for ZY, ATIP and SAVA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

Accesswire August 31, 2021

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Cassava Sciences, Inc. (SAVA) Investors

Business Wire August 31, 2021

Lawsuits Filed Against JRVR, SAVA and HYRE - Jakubowitz Law Pursues Shareholders Claims

Accesswire August 31, 2021

SAVA Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Cassava Sciences, Inc. Investors of Class Action and Encourages Investors to Contact the Firm

PR Newswire August 31, 2021

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Cassava Sciences, Inc. (SAVA) Investors to Contact Firm's Attorneys Now, Securities Fraud Case Filed

PR Newswire August 31, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KPLT, SAVA and HYRE

Accesswire August 31, 2021

SAVA DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Cassava Sciences, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case

PR Newswire August 30, 2021